73665 Bimekizumab treatment resulted in long-term maintenance of complete clinical resolution across skin, joint, and nail domains in patients with active psoriatic arthritis: 3-year results from two phase 3 studies
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB83
DOI: 10.1016/j.jaad.2026.04.342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Joseph F. Merola und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Merola, J. F., Gisondi, P., Morita, A., Gossec, L., Tillett, W., Walsh, J. A., Ink, B., Bajracharya, R., Coarse, J., & Thaçi, D. (2026). 73665 Bimekizumab treatment resulted in long-term maintenance of complete clinical resolution across skin, joint, and nail domains in patients with active psoriatic arthritis: 3-year results from two phase 3 studies. Journal of the American Academy of Dermatology, 95(1), AB83. https://doi.org/10.1016/j.jaad.2026.04.342
Vancouver
Merola JF, Gisondi P, Morita A, Gossec L, Tillett W, Walsh JA, et al. 73665 Bimekizumab treatment resulted in long-term maintenance of complete clinical resolution across skin, joint, and nail domains in patients with active psoriatic arthritis: 3-year results from two phase 3 studies. Journal of the American Academy of Dermatology. 2026;95(1):AB83. doi:10.1016/j.jaad.2026.04.342
BibTeX
@article{Merola2026,
author = {Merola, Joseph F. and Gisondi, Paolo and Morita, Akimichi and Gossec, Laure and Tillett, William and Walsh, Jessica A. and Ink, Barbara and Bajracharya, Rajan and Coarse, Jason and Thaçi, Diamant},
title = {73665 Bimekizumab treatment resulted in long-term maintenance of complete clinical resolution across skin, joint, and nail domains in patients with active psoriatic arthritis: 3-year results from two phase 3 studies},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB83},
doi = {10.1016/j.jaad.2026.04.342}
}
EUVIMED